Literature DB >> 16220453

Mechanisms of disease: PI3K/AKT signaling in gastrointestinal cancers.

P Michl1, J Downward.   

Abstract

The lipid kinase phosphoinositide 3-OH kinase (PI3K) and its downstream target Akt, also known as protein kinase B (PKB), are crucial effectors in oncogenic signaling induced by various receptor-tyrosine kinases. In recent years, data are accumulating that PI3K/Akt signaling components are frequently altered in a variety of human malignancies. This review summarizes the major effects of PI3K/Akt signaling on proliferation, survival and resistance to apoptosis, angiogenesis and cell motility in gastrointestinal cancers. In addition, activation of PI3K/Akt by various growth factors, the modulation of downstream targets by Akt-induced phosphorylation as well as novel treatment strategies targeting this pathway in gastrointestinal tumors are discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16220453     DOI: 10.1055/s-2005-858638

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  44 in total

1.  Airway PI3K pathway activation is an early and reversible event in lung cancer development.

Authors:  Adam M Gustafson; Raffaella Soldi; Christina Anderlind; Mary Beth Scholand; Jun Qian; Xiaohui Zhang; Kendal Cooper; Darren Walker; Annette McWilliams; Gang Liu; Eva Szabo; Jerome Brody; Pierre P Massion; Marc E Lenburg; Stephen Lam; Andrea H Bild; Avrum Spira
Journal:  Sci Transl Med       Date:  2010-04-07       Impact factor: 17.956

2.  FoxO4 is the main forkhead transcriptional factor localized in the gastrointestinal tracts of pigs.

Authors:  Zhen-qi Zhou; Tian Wang; Ling-mei Pan; Rui-hua Huang; Fang-xiong Shi
Journal:  J Zhejiang Univ Sci B       Date:  2007-01       Impact factor: 3.066

3.  Ras, PI3K/Akt and senescence: Paradoxes provide clues for pancreatic cancer therapy.

Authors:  Alyssa L Kennedy; Peter D Adams; Jennifer P Morton
Journal:  Small GTPases       Date:  2011-09-01

4.  Glycogen synthase kinase-3beta induces neuronal cell death via direct phosphorylation of mixed lineage kinase 3.

Authors:  Rajakishore Mishra; Manoj K Barthwal; Gautam Sondarva; Basabi Rana; Lucas Wong; Malay Chatterjee; James R Woodgett; Ajay Rana
Journal:  J Biol Chem       Date:  2007-08-21       Impact factor: 5.157

5.  Epithelial cell-derived periostin functions as a tumor suppressor in gastric cancer through stabilizing p53 and E-cadherin proteins via the Rb/E2F1/p14ARF/Mdm2 signaling pathway.

Authors:  Hongjun Lv; Rui Liu; Jiao Fu; Qi Yang; Jing Shi; Pu Chen; Meiju Ji; Bingyin Shi; Peng Hou
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

6.  SGT1 regulates Akt signaling by promoting beta-TrCP-dependent PHLPP1 degradation in gastric cancer cells.

Authors:  Ganglong Gao; Tao Kun; Youhua Sheng; Min Qian; Fanzhi Kong; Xiaoguang Liu; Zhenfeng Yu; Haiqin Zhang; Qiang Zhang; Jianping Gu; Xueli Zhang
Journal:  Mol Biol Rep       Date:  2013-02-26       Impact factor: 2.316

7.  Macrophage migration inhibitory factor regulates proliferation of gastric cancer cells via the PI3K/Akt pathway.

Authors:  Guo-Qing Li; Juan Xie; Xiao-Yong Lei; Li Zhang
Journal:  World J Gastroenterol       Date:  2009-11-28       Impact factor: 5.742

8.  Targeting AKT with the proapoptotic peptide, TAT-CTMP: a novel strategy for the treatment of human pancreatic adenocarcinoma.

Authors:  Peter O Simon; Jonathan E McDunn; Hiroyuki Kashiwagi; Katherine Chang; Peter S Goedegebuure; Richard S Hotchkiss; William G Hawkins
Journal:  Int J Cancer       Date:  2009-08-15       Impact factor: 7.396

9.  Phosphorylation status of Akt and caspase-9 in gastric and colorectal carcinomas.

Authors:  Akiko Sangawa; Michiko Shintani; Naoki Yamao; Shingo Kamoshida
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

Review 10.  The liver-brain axis of alcohol-mediated neurodegeneration: role of toxic lipids.

Authors:  Suzanne M de la Monte; Lisa Longato; Ming Tong; Sarah DeNucci; Jack R Wands
Journal:  Int J Environ Res Public Health       Date:  2009-07-23       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.